March 17, 2020 / 7:38 PM / 23 days ago

BRIEF-Enzychem Lifesciences Announces Plans To Advance Clinical Trial In South Korea For EC-18 As A Potential Therapeutic For COVID-19 Infection

March 17 (Reuters) - Enzychem Lifesciences Corp:

* ENZYCHEM LIFESCIENCES ANNOUNCES PLANS TO ADVANCE CLINICAL TRIAL IN SOUTH KOREA FOR EC-18 AS A POTENTIAL THERAPEUTIC FOR COVID-19 INFECTION

* ENZYCHEM LIFESCIENCES - BEEN IN COMMUNICATION WITH RELEVANT U.S. GOVERNMENT AUTHORITIES FOR DEVELOPMENT COLLABORATION FOR CORONAVIRUS TREATMENT

* ENZYCHEM LIFESCIENCES - ADVANCING RESEARCH COLLABORATION FOR DEVELOPMENT OF EC-18 WITH VARIOUS GOVERNMENT AUTHORITIES OF CHINA & KOREA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below